Position in RYTM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,914,435
+$356,660 QoQ
Shares Held
197,374
-20.4% QoQ
Ownership
0.287%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Derivatives in RYTM
reported options exposure · as of Mar 31, 2023CallValue
$10,846
CallShares
608
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,331,911,014 across 414 Biotechnology names. RYTM ranks #45 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in RYTM
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,914,435 | 197,374 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $21,557,775 | 247,876 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $17,614,823 | 164,563 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $22,589,544 | 223,681 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,460,482 | 102,239 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,558,916 | 86,066 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,772,239 | 85,249 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $755,725 | 14,425 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $145,475 | 3,543 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,426,869 | 56,009 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $2,900,017 | 63,085 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,266,445 | 55,243 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $879,823 | 53,355 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $10,846 | 608 | Call | Defined | 2023-05-12 | |
| 2023-03-31 | $1,552,829 | 87,042 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,539,982 | 52,884 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,982,858 | 80,933 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $85,431 | 20,586 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $135,521 | 11,764 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $372,992 | 37,374 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $142,458 | 10,908 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $103,715 | 5,297 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $313,392 | 14,734 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $143,120 | 4,814 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $171,496 | 7,914 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $59,808 | 2,682 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $194,207 | 12,760 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||